Based on two HNSCC mouse models, it was demonstrated that the use of Gel-N-ICG nanoparticles with laser irradiation led to the inhibition of tumour microenvironment immunosuppression (TME) and reduction in the population of PD-1 cells, and increased the anti-cancer efficacy of the therapy [576]. The gene discussed is PDCD1; the disease is cancer.